Zomedica Corp. Operating Income Loss

• Zomedica Corp. showed a decrease of -65.2% in Operating Income Loss from 2024 to 2025.
• This data is from Zomedica Corp.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Zomedica Corp.'s Operating Income Loss has declined by 1,373.1%.
• Historical annual values: Fiscal year 2025: -$84.35 million | Fiscal year 2024: -$51.05 million | Fiscal year 2023: -$43.28 million | Fiscal year 2022: -$21.92 million | Fiscal year 2021: -$21.37 million | Fiscal year 2020: -$16.76 million | Fiscal year 2019: -$19.78 million | Fiscal year 2018: -$16.58 million | Fiscal year 2017: -$8.08 million | Fiscal year 2016: -$5.73 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026